US FDA News: Statement on the agency’s ongoing efforts to resolve safety issue with ARB medications

The FDA is issuing an update regarding the ongoing efforts to resolve safety issues with ARB medications.
Read more: Statement on the agency’s ongoing efforts to resolve safety issue with ARB medications